ClinicalTrials.gov
public full text
Public Domain
The Additive Value of Pyridostigmine to Silodosin in Acute Urinary Retention
Acute urine retention, AUR, is often considered the most serious consequence of aging men with progressive benign prostatic hyperplasia (BPH). AUR is defined as the sudden and painful inability to void freely. This study aims to evaluate whether pyridostigmine bromide added to silodosin is beneficial in treating acute urine retention caused by BPH.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Early Electroacupuncture for Post-TURP LUTS#896343
- A Study of Tadalafil in Men With Benign Prostatic Hyperplasia#1075001
- Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms#866114
- Fesoterodine "add-on" Male Overactive Bladder Study#1046783
- Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder#844449
Record · ID 888835
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive